Brain targeting of quetiapine fumarate via intranasal delivery of loaded lipospheres: fabrication, in-vitro evaluation, optimization, and in-vivo assessment

HIGHLIGHTS

• who: Randa Mohammed Zaki et al. from the Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, POBox, Al-Kharj, Saudi Arabia have published the research work: Brain Targeting of Quetiapine Fumarate via Intranasal Delivery of Loaded Lipospheres: Fabrication, In-Vitro Evaluation, Optimization, and In-Vivo Assessment, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of 26/07/2022
• what: The aim of this study was to develop QTF lipospheres for intranasal delivery of QTF to the brain. The study received clearance from the Institutional Animal Ethical Committee (IAEC) number 202010001 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.